JS InnoPharm is a clinical stage biotech company focused on discovery and development of innovative small molecule oncology medicines to help patients with unmet medical needs.  Driven by innovative oncology translation research, we are advancing an innovative pipeline by internal R&D as well as global partnering, and developing multiple clinical candidates with differential clinical strategies for both US and China.